Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets ... Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others. Mehr anzeigen
WESTPORT, Conn., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.48 | 11.5942028986 | 4.14 | 4.78 | 3.8 | 36441 | 4.42099283 | CS |
| 4 | -1.6 | -25.7234726688 | 6.22 | 7.11 | 3.8 | 41209 | 5.09654081 | CS |
| 12 | 0.07 | 1.53846153846 | 4.55 | 23.01 | 2.81 | 973488 | 9.53085726 | CS |
| 26 | -0.38 | -7.6 | 5 | 23.01 | 2.098 | 1328337 | 6.59363279 | CS |
| 52 | -23.78 | -83.7323943662 | 28.4 | 40.8 | 2.098 | 727661 | 6.80292589 | CS |
| 156 | -380.58 | -98.800623053 | 385.2 | 407.43 | 2.098 | 260512 | 14.74467774 | CS |
| 260 | -745.38 | -99.384 | 750 | 899.526 | 2.098 | 215607 | 30.2291397 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
